| Educational Session |
08:30-09:40 |
| 1:Innovative treatment of medical oncology |
Crystal Ballroom A |
| 1) Innovative treatment of malignant lymphoma |
| Seok Jin Kim (Samsung Medical Center) |
| 2) Innovative treatment of lung cancer |
| Eun Joo Kang (Korea University College of Medicine) |
| 3) Innovative treatment of ovarian cancer |
| Jae Ho Byun (The Catholic University of Korea College of Medicine) |
| 2:Current status and future perspectives of radiotherapy in hepatocellular carcinoma |
Crystal Ballroom B |
| 1) Radiotherapeutic strategies in management of hepatocellular carcinoma |
| Jinsil Seong (Yonsei University College of Medicine) |
| 2) Recent updates on precision radiotherapy for hepatocellular carcinoma |
| Hee Chul Park (Samsung Medical Center) |
| 3) Radiation induced hepatic toxicity and how to avoid it |
| Tae Hyun Kim (National Cancer Center) |
| 3: Updated management of peritoneal surface maliganancy |
Crystal Ballroom C |
| 1) Peritoneactomy |
| Myong Cheol Lim (National Cancer Center) |
| 2) Updated management of peritoneal surface malignancy: HIPEC |
| Seung Hyuk Baik (Yonsei University College of Medicine) |
| 3) EPIC for gastric cancer
|
| Oh Kyoung Kwon (Kyungpook National University School of Medicine) |
|
| Young Investigator Symposium (I) |
08:30-09:40, Sapphire Ballroom B |
| 1) Next-generation sequencing analysis of clinical tissue samples |
| Guhyun Kang (Inje University College of Medicine) |
| 2) Clinical pharmacologic aspects of immune checkpoint inhibitors in cancer therapy |
| Kyu-pyo Kim (Asan Medical Center) |
|
| Young Investigator Symposium (II) |
08:30-09:40, Sapphire Ballroom C |
| 1) Cripto-1 elicits intrinsic resistance to EGFR tyrosine kinase inhibitors via miR-205/SRC axis in Non-Small cell lung cancer
harboring EGFR-Sensitizing mutations |
| Kang-Seo Park (Asan Medical Center) |
| 2) How to overcome TRAIL resistance in cancer stem cells ? |
| Dae-Hee Lee (Korea University College of Medicine) |
| 3) Function of tumour-stroma in gastric cancer progression |
| Hoon Hur (Ajou University School of Medicine) |
|
| Plenary Lecture 1 Eng |
10:00-10:30, Crystal Ballroom |
| Evolution of systemic treatment for advanced gastric cancer |
| Yung-Jue Bang, M.D., Ph.D. (Seoul National University College of Medicine) |
|
| Plenary Lecture 2 Eng |
10:30-11:20, Crystal Ballroom |
| Hypoxia, metabolism, and tumor progression |
| M. Celeste Simon , Ph.D. (Department of Cell and Developmental Biology, University of Pennsylvania School of Medicine, USA) |
|
| Gastric Cancer Master Class |
10:30-13:00, Belle-vue Suite |
| 1) Current standard care of adjuvant/neoadjuvant approach in gastric cancer |
| Yeul Hong Kim (Korea University College of Medicine) |
| 2) Metastatic gastric cancer treatment: review of immunotherapy clinical trial |
| Kohei Shitara (National Cancer Center Hospital, Japan) |
| 3) Translational research for gastric cancer |
| Do-Youn Oh (Seoul National University Hospital) |
| 4) Panel Case Discussion |
Matthew Ng (National Cancer Center Singapore, Singapore)
Yee Chao (Taipei Veterans General Hospital, Taiwan) |
|
| Symposium 1 Eng |
12:40-14:20, Crystal Ballroom A |
| Joint Symposium (Korean Cancer Association & Korea Genome Organization) |
|
Driving new omics-approaches to precision medicine |
| 1) Real-world application of NGS to advanced lung cancer patients |
| Se-Hoon Lee (Samsung Medical Center) |
| 2) Genetic understanding of liposarcoma |
| Murim Choi (Seoul National University College of Medicine) |
| 3) Molecular prognostication of cholangiocarcinoma |
| Hyun Goo Woo (Ajou University School of Medicine) |
| 4) Transposable elements-associated structure variation from Korean genome |
| Kyudong Han (Dankook University) |
|
| Symposium 2 |
12:40-14:20, Crystal Ballroom B |
| Joint Symposium (Korean Cancer Association & Korean Society of Radiation Bioscience) |
| Immune modulation by radiation therapy |
| 1) Immune modulation by radiation |
| Jie-Young Song (Korea Institute of Radiological & Medical Sciences) |
| 2) Hypoxia and immune modulation |
| G-One Ahn (Pohang University of Science and Technology) |
| 3) Tumor hypoxia and radiation therapy |
| Kwangmo Yang (Dongnam Institute of Radiological & Medical Sciences) |
| 4) In vivo imaging of immune modulation |
| Myung Geun Song (Seoul National University College of Medicine) |
|
| Symposium 3 |
12:40-14:20, Crystal Ballroom C |
| Joint Symposium (Korean Cancer Association & The Korean Society of Pathologists) |
| Companion diagnostics in pathology for precision medicine |
| 1) Points to consider in the development of in vitro companion diagnostic devices: assay selection, validation, compliance, and reimbursement issue |
| Young Kee Shin (Seoul National University College of Pharmacy) |
| 2) Companion biomarkers in breast cancer |
| Chungyeul Kim (Korea University College of Medicine) |
| 3) Biomarkers and companion diagnotics for lung cancer in the era of precision medicine |
| Lucia Kim (Inha University School of Medicine) |
| 4) Molecular diagnosis and research for precision medicine in gastrointestinal cancer |
| Hye Seung Lee (Seoul National University Bundang Hospital) |
| 5) Guidance for in vitro companion diagnostic devices |
| Hyeonjoo Oh (Ministry of Food & Drug Safety) |
|
| Symposium 4 Eng |
12:40-14:20, Sapphire Ballroom B |
| Joint Symposium (Korean Cancer Association & Shanghai Cancer Institute) |
| Novel strategies for cancer therapy (I) |
| 1) New insights into cellular origin of prostate epithelial development and tumorigenesis |
| Wei-Qiang Gao (Shanghai Cancer Institute, China) |
| 2) Experimental therapeutic strategies for targeting HCC cancer stem cells |
| Jinjun Li (Shanghai Cancer Institute, China) |
| 3) Complex adaptaive therapeutic strategy (CATS) for cancer control |
| In-San Kim (Korea Institute of Science & Technology / Korea University) |
| 4) Clinical sequencing and developing PDX model for genitourinary cancers |
| Yeun-Jun Chung (The Catholic University of Korea College of Medicine) |
|
| Symposium 5 Eng |
14:40-16:20, Crystal Ballroom A |
| Joint Symposium (Korean Cancer Association & Korean Association for Lung Cancer) |
| How to mobilize immune system to combat lung cancer? |
| 1) Basic concept of immune checkpoint inhibition |
| Eui-Cheol Shin (KAIST) |
| 2) Anti-PD1 and anti-PDL1 strategies in NSCLC |
| Ross Soo (National University of Hospital of Singapore, Singapore) |
| 3) Balanced radiotherapy effect on immunomodulation in lung cancer |
| Si Yeol Song (Asan Medical Center) |
| 4) Case discussion |
Hyo Sup Shim (Yonsei University College of Medicine),
Byoung Chul Cho (Yonsei University College of Medicine) |
|
| Symposium 6 |
14:40-16:20, Crystal Ballroom B |
| Survivorship in rapidly changing landscape of cancer care |
|
|
| 1) Changing paradigm of caregiving in precision medicine and immuno-oncology era |
| Dae Ho Lee (Asan Medical Center) |
| 2) Needs in community programs to disseminate lifestyle intervention |
| Sang Min Park (Seoul National University College of Medicine)
|
| 3) Integrating psycho-oncology to improve mental-care for elderly survivors |
| Hye Youn Park (Seoul National University Bundang Hospital)
|
| 4) Late effect of young adult survivors including pediatrics, adolescent and young adults |
| Jung Woo Han (Yonsei University College of Medicine)
|
|
| Symposium 7 Eng |
14:40-16:20, Crystal Ballroom C |
|
Exploring non-coding RNAs: Fine tuners in tumorigenesis |
| 1) nc886, a novel type of non-coding RNA that links the TGF-beta and miRNA pathways |
| Yong Sun Lee (University of Texas Medical Branch, USA) |
| 2) Clinical applications of microRNAs in pancreatic cancer |
| Jin-Hyeok Hwang (Seoul National University Bundang Hospital) |
| 3) Role of viral miRNAs in EBV-associated gastric carcinoma |
| Suk Kyeong Lee (The Catholic University of Korea College of Medicine) |
| 4) Bioinformatics approaches: miRNAs and cancer |
| Seungyoon Nam (Gachon University College of Medicine) |
|
| Symposium 8 Eng |
14:40-16:20, Sapphire Ballroom B |
| Joint Symposium (Korean Cancer Association & Shanghai Cancer Institute) |
| Novel strategies for cancer therapy (II) |
| 1) Development of cancer-specific anti-EGFR CAR-T cells for the treatment of patients with glioblastoma |
| Zonghai Li (Shanghai Cancer Institute, China) |
| 2) Serotonin system in pancreatic ductal adenocarcinoma |
| Zhigang Zhang (Shanghai Cancer Institute, China) |
| 3) Microenvironmental regulation of tumor progression in glioma |
| Su-Jae Lee (Hanyang University College of Natural Sciences) |
| 4) Development of HER2 aptamer-DM1 conjugate for HER2 (+) breast cancer |
| Jae Hong Seo (Korea University College of Medicine) |
|
| Symposium 9 Eng |
14:00-16:00, Belle-vue Suite |
| Joint Symposium (Korean Cancer Association & UICC-ARO) |
| Cancer and Universal Health Coverage (UHC) in Asia |
| 1) Universal health coverage of cancer in Korea: Prospect and challenge |
| Eun-Cheol Park (Yonsei University College of Medicine, Korea) |
| 2) UHC in Japan: Prospect and challenge |
| Shinjiro Nozaki (WHO Kobe Center, Japan) |
| 3) Household burden on treating cancer and the Universal Health Coverage in Indonesia |
| Hasbullah Thabrany (Universitas Indonesia, Indonesia) |
| 4) What is the Cross-Boundary studies in the future university?: Globalization and the new era of human knowledges |
| Shunya Yoshimi (The University of Tokyo, Japan) |
| 5) The road toward UHC: Promoting cancer education in community |
| Norie Kawahara (The University of Tokyo, Japan) |
| 6) UHC and equality of cancer statistics in Korea |
| Sohee Park (Graduate School of Public Health, Yonsei University, Korea) |
| 7) UHC and Comprehensive plan of cancer control in Korea |
| Duk Hyoung Lee (National Cancer Center, Korea) |
|
| Symposium 10 Eng |
16:20-18:00, Crystal Ballroom A |
|
Imaging companion diagnostic |
| 1) Molecular imaging based targeted therapy |
| Ho-Young Lee (Seoul National University Bundang Hospital ) |
| 2) Theranostics in cancer treatment |
| Byeong-Cheol Ahn (Kyungpook National University School of Medicine) |
| 3) Imaging guided therapy in brain tumors |
| Seung Hong Choi (Seoul National University College of Medicine) |
|
| Symposium 11 Eng |
16:20-18:00, Crystal Ballroom C |
|
Evidence and guideline for cancer prevention and screening in Korea |
| 1) PAF (Population Attributable Factors) estimation for cancer development |
| Sohee Park (Graduate School of Public Health, Yonsei University) |
| 2) Development of evidence based 10 codes and guidelines for cancer prevention in Korea |
| Min Kyung Lim (National Cancer Center) |
| 3) Seven cancer screening guideline revised/developed by evidence-based methods |
| Yeol Kim (National Cancer Center) |
| 4) Randomized controlled trial on Helicobacter pylori eradication effect for gastric cancer prevention |
| Il Ju Choi (National Cancer Center) |
|
| Satellite Symposium 1 Eng |
11:30-12:20, Crystal Ballroom |
| Immunotherapy, a new paradigm shift for NSCLC (by MSD) |
| Pouliot, Jean Francois (Director, International medical leader for lung cancer, MSD) |
|
| Oral Presentation 1 |
12:40-14:20, Pine Room |
|
| Oral Presentation 2 |
12:40-14:20, Sapphire Ballroom A |
|
| Oral Presentation 3 |
14:40-16:20, Pine Room |
|
| Oral Presentation 4 |
16:20-18:00, Crystall Ballroom B |
|
| Oral Presentation 5 |
16:20-18:00, Pine Room |
|
|
| International Session 1 (Oral)Eng |
14:40-16:20, Sapphire Ballroom A |
|
| International Session 2 (Oral)Eng |
16:20-18:00, Sapphire Ballroom A |
|
| International Session 3 (Oral)Eng |
16:20-18:00, Sapphire Ballroom B |
|
| International Session 4 (Oral)Eng |
16:20-18:00, Sapphire Ballroom C |
|
| Poster Presentation |
09:00-17:00, Emerald Room |
|
|
